RMTG
Regenerative Medical Technology Group Inc.
-0.01 (-9.09%)0.08USD85.7K成交股數1.0M市值–本益比(近四季)0.1股價營收比+309.1%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 4.0M+309% | 2.6M+93% | 1.6M+59% | 1.2M+49% | 983K+20% | 1.4M+122% | 986K+52% | 793K+120% | 817K | 616K | 647K | 361K |
| 營業成本 | 1.4M | 873K | 792K | 679K | 398K | 420K | 239K | 266K | 248K | 181K | 197K | 108K |
| 毛利 | 2.6M+340% | 1.8M+87% | 780K+4% | 502K-5% | 586K+3% | 944K+117% | 747K+66% | 527K+108% | 569K | 435K | 450K | 254K |
| 毛利率 | 64.1% | 66.9% | 49.6% | 42.5% | 59.6% | 69.2% | 75.7% | 66.4% | 69.6% | 70.6% | 69.6% | 70.2% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 619K | 476K | 389K | 278K | 207K | 246K | 264K | 262K | 159K | 374K | 147K | 232K |
| 營業利益 | 566K-326% | 230K+70% | −306K-1659% | −446K+108% | −250K+138% | 135K | 20K | −214K | −105K | – | – | – |
| 營業利益率 | 14.1% | 8.7% | -19.5% | -37.8% | -25.4% | 9.9% | 2.0% | -27.0% | -12.9% | – | – | – |
| 稅後淨利 | −2.9M+101% | −876K+15% | −1.3M+41% | −4.4M+110% | −1.4M-26% | −760K+197% | −887K-85% | −2.1M+2% | −2.0M | −256K | −5.9M | −2.0M |
| 淨利率 | -72.2% | -33.2% | -79.8% | -368.8% | -146.8% | -55.7% | -89.9% | -261.8% | -240.0% | -41.6% | -905.5% | -561.8% |
| 稀釋 EPS | -0.22+83% | -0.07+17% | -0.09+29% | -0.35+106% | -0.12-25% | -0.06+100% | -0.07-85% | -0.17+6% | -0.16 | -0.03 | -0.47 | -0.16 |
| 稀釋股數 | 13.2M | 13.1M | 12.6M | 12.5M | 12.5M | 12.5M | 12.5M | 12.5M | 12.5M | 12.4M | 12.4M | 12.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 1.3M | 1.1M | 957K | 1.2M | 1.6M | 1.2M | 836K | 617K | 579K | 531K | 1.1M | 1.2M |
| 應收帳款 | 110K | 35K | 44K | 114K | 37K | 16K | – | 24K | 44K | 24K | 35K | 51K |
| 存貨 | 481K | 298K | 159K | 156K | 106K | 23K | – | 7K | – | – | – | – |
| 總資產 | 5.9M | 5.0M | 4.5M | 4.5M | 4.5M | 4.0M | – | 3.1M | 3.1M | 2.9M | 3.3M | 7.5M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 45.1M | 40.6M | 40.5M | 34.6M | 33.5M | 32.1M | – | 28.9M | 26.8M | 24.7M | 24.9M | 23.2M |
| 股東權益 | −39.3M | −36.4M | −36.0M | −30.1M | −29.0M | −28.1M | −26.7M | −25.8M | −23.8M | −21.8M | −21.5M | −15.7M |
| 負債比 | 771.0% | 811.1% | 903.1% | 764.9% | 746.8% | 806.3% | – | 947.0% | 871.6% | 857.0% | 749.8% | 307.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 102K+79% | – | – | – | 57K | – | – | 108K | – | – | – |
| 資本支出 | – | 315K | – | – | – | – | – | – | 59K | – | – | – |
| 自由現金流 | – | −213K | – | – | – | – | – | – | 49K | – | – | – |
| 折舊攤銷 | 91K | 98K | 98K | 76K | 55K | 52K | 89K | 83K | 77K | – | – | 58K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -8.1% | – | – | – | – | – | – | 6.0% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 5.1M
| Product Supplies | 2.0M | 39.7% | +15.8% |
|---|---|---|---|
| Patient Procedures | 1.9M | 36.8% | +36.7% |
| Training | 1.1M | 22.1% | +39.0% |
| Equipments | 76K | 1.5% | -57.2% |
| Global Stem Cells Group 小計 | 5.1M | 100.0% | – |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 5.1M | +24.2% | −7.8M | -153.2% | -0.62 | −1.3M |
| FY2024 | 4.1M | +70.4% | −5.6M | -135.4% | -0.44 | 635K |
| FY2023 | 2.4M | +57.5% | −9.8M | -407.2% | -0.79 | −805K |
| FY2022 | 1.5M | +249.5% | −5.5M | -359.9% | -0.45 | −1.3M |
| FY2021 | 438K | +695.0% | −12.9M | -2,942.4% | -1.12 | – |
| FY2020 | 55K | +83.0% | −5.9M | -10,703.5% | -0.63 | −423K |
| FY2019 | 30K | – | −2.5M | -8,335.2% | -0.47 | −462K |
| FY2019 | – | – | −1.7M | –% | – | – |